The role of six biomarkers in diagnosis of hemophilic arthropathy: review of the literature

G. Pasta, E. Jannelli, A. Ivone, M. Mosconi, E.Ferranti Calderoni, A. Minen, F. Benazzo, E.C. Rodriguez-Merchan

Article ID: 5711
Vol 34, Issue 3S2, 2020
DOI: https://doi.org/10.54517/jbrha5711
Received: 9 July 2020; Accepted: 9 July 2020; Available online: 9 July 2020; Issue release: 9 July 2020

Abstract

The aim of our narrative review of the literature is to identify the role of six important biomarkers: synovial fluid thrombomodulin, fibroblast-like synoviocytes, synovial tissue growth factor , vascular endothelial growth factor in synovium and peripheral blood, urinary C-terminal telopeptide of type II collagen, and synovial fluid tumor necrosis factor alpha. These urinary, serum and synovial biomarkers illustrated should be evaluated in patients with hemophilic arthropathy for early diagnosis of hemophilic arthropathy, because they have important implications in the development of arthrofibrosis, altered inflammatory response and bleeding. Moreover, better knowledge of their biological activity is important to identify possible new biological treatment options.


Keywords

hemophilia;hemophilic arthropathy;biomarkers;hemarthrosis;synovitis


References

Supporting Agencies



Copyright (c) 2020 G. Pasta, E. Jannelli, A. Ivone, M. Mosconi, E.Ferranti Calderoni, A. Minen, F. Benazzo, E.C. Rodriguez-Merchan




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).